Drug Type circular RNA |
Synonyms |
Target |
Action inhibitors |
Mechanism OTUB1 inhibitors(OTU deubiquitinase, ubiquitin aldehyde binding 1 inhibitors), RAB8A inhibitors(RAB8A, member RAS oncogene family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Discovery | China | 09 Jan 2025 |